• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-21

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon processing, and DNA damage responses in hepatocellular carcinoma. SmD2 depletion increased PARP inhibitor sensitivity, while combining HDAC inhibition with olaparib produced therapeutic activity in preclinical HCC models, suggesting a route to address PARP inhibitor limitations beyond BRCA1/2-deficient tumors.

• Molecular Tools for A40926 Production

  2026-08-20

  Yushchuk et al. developed a promoter-reporter toolkit for the genetically challenging actinobacteria Nonomuraea gerenzanensis and Nonomuraea coxensis. By identifying a strong constitutive promoter and overexpressing pathway-specific regulatory genes, the study achieved a knowledge-based increase in A40926 glycopeptide antibiotic production, including evaluation at bioreactor scale.

• DRB in Transcriptional Elongation Research

  2026-08-20

  DRB provides a rapid, reversible way to interrogate RNA polymerase II output, CTD kinase activity, and transcription-dependent cell-state transitions. This guide connects practical dose-finding and RNA assays with the YTHDF1 phase-separation study while highlighting controls, limitations, and antiviral research applications.

• HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody

  2026-08-19

  Translate human IgG binding into bright, flexible readouts across immunofluorescence, Western blotting, flow cytometry, IHC, and ELISA. This affinity-purified Alexa Fluor 488 secondary supports signal amplification while providing practical storage, dilution, and troubleshooting guidance for translational assay development.

• Dicloxacillin Activity Against Intracellular S. aureus

  2026-08-19

  Sandberg et al. integrated THP-1 cell and murine peritonitis models to compare dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Their results identify free-drug exposure above the MIC, rather than a single concentration or exposure metric, as the most informative pharmacokinetic/pharmacodynamic predictor in both compartments.

• EDC.HCl Coupling Workflow Guide

  2026-08-18

  EDC.HCl is a water-soluble carbodiimide for activating carboxyl groups before amide bond formation with primary amines in peptide synthesis and bioconjugation. This dossier-led guidance is intended for controlled in vitro laboratory workflows; no in vivo or clinical data are reported, so those uses are not supported.

• Olive Oil Polyphenols in Cardiovascular Protection

  2026-08-18

  The reference study compares standard and naturally high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol across oxidative, inflammatory, and cholesterol-efflux assays. Its main contribution is showing that polyphenol concentration and chemical context can shape cardioprotective activity, while also identifying hydroxytyrosol as a particularly active experimental comparator.

• Gepotidacin for Uncomplicated Urogenital Gonorrhea

  2026-08-17

  This phase 2 randomized study evaluated whether a single oral dose of the novel topoisomerase inhibitor gepotidacin could eradicate uncomplicated urogenital Neisseria gonorrhoeae infections. Both tested doses achieved at least 95% microbiological eradication in the evaluable population, supporting further development while highlighting the need to monitor susceptibility-associated mutations and assess broader anatomical and clinical populations.

• Cinoxacin Workflows for Gram-Negative Research

  2026-08-17

  Cinoxacin supports practical susceptibility, bactericidal, and resistance-selection workflows centered on aerobic Gram-negative urinary pathogens. Its historical agar-dilution and disk-diffusion performance also provides a useful framework for connecting MIC measurements with applied urinary tract infection research.

• Firefly Luciferase mRNA: Delivery and Assay Guide

  2026-08-16

  Build more reproducible reporter assays with Cap1-capped, 5-moUTP modified mRNA for sensitive translation, delivery, viability, and imaging studies. This practical guide connects transcript handling and transfection design with lipid nanoparticle process choices, including concentration, buffer, and storage variables.

• Liproxstatin-1 Workflow for Ferroptosis Research

  2026-08-15

  Build more discriminating ferroptosis assays with Liproxstatin-1, a nanomolar small-molecule ferroptosis inhibitor that separates lipid-peroxidation-driven death from apoptosis and nonspecific oxidative injury. This practical guide covers dosing, BODIPY-based readouts, GPX4-deficient cell protection, renal injury models, and the membrane-remodeling insights of a recent Science Advances study.

• Carbapenemase Gene Dynamics in CREC, Guangdong

  2026-08-15

  Chen et al. profiled 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong and combined gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and ERIC-PCR typing. The high prevalence and transferability of blaNDM-1, together with multidrug resistance and interhospital genotypic overlap, highlight the need to monitor both plasmid-mediated and clonal dissemination.

• Cinoxacin: From MIC to UTI Assay Design

  2026-08-14

  Cinoxacin is a quinolone antibiotic best understood through the relationship between susceptibility, bacterial killing, and urinary exposure. This assay-focused guide translates its spectrum, pharmacology, and historical comparative evidence into practical decisions for urinary tract infection research and antibiotic resistance studies.

• Cefazedone Assay Design: From MIC to PK/PD

  2026-08-14

  Cefazedone (Refosporen) assay design requires more than a single MIC value. This guide connects broth-dilution methodology, resistant-isolate comparisons, β-lactamase interpretation, and free-drug PK/PD to build more reproducible antibacterial studies.

• Ceftolozane sulfate: Assay and PK/PD Workflows

  2026-08-13

  Build more reproducible Gram-negative antibacterial studies with Ceftolozane sulfate, from MIC testing to time-kill and animal PK/PD experiments. This workflow emphasizes isolate stratification, AmpC stability, exposure-driven interpretation, and resistance-aware troubleshooting for Pseudomonas aeruginosa research.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page